|
Glioblastoma / Treatment
|
|
Poly-ICLC (Polyinosinic-polycytidylic acid stabilized with
polylysine and carboxymethylcellulose)
|
|
Home >
Database > Glioblastoma
> Treatment
>
Poly-ICLC
|
|
|
Contents
|
|
|
|
Glioblastoma
|
|
|
|
|
Butowski N, Chang SM, Junck L, Deangelis LM,
Abrey L, Fink K, Cloughesy T, Lamborn KR, Salazar AM, Prados MD.
A phase II clinical trial of poly-ICLC with radiation for adult patients
with newly diagnosed supratentorial glioblastoma: a North American Brain
Tumor Consortium (NABTC01-05)
J Neurooncol. 2008 Sep 17; [Epub ahead of print]
.JPG)
Abstract
|
|
|
Rosenfeld
MR, Chamberlain MC, Grossman SA, Peereboom DM, Lesser GJ, Batchelor TT,
Desideri S, Salazar AM, Ye X.
A multi-institution phase II study of poly-ICLC and radiotherapy with
concurrent and adjuvant temozolomide in adults with newly diagnosed
glioblastoma
Neuro Oncol. 2010 Jul 8;. [Epub ahead of print]
Abstract
|
|
|
Gliomas
(High-Grade)
|
|
|
|
Salazar AM, Levy HB, Ondra S, Kende M, Scherokman B, Brown D, Mena H, Martin
N, Schwab K, Donovan D, Dougherty D, Pulliam M, Ippolito M, Graves M, Brown H,
Ommaya A.
Long-term treatment of malignant gliomas with intramuscularly
administered polyinosinic-polycytidylic acid stabilized with polylysine and
carboxymethylcellulose: an open pilot study
Neurosurgery 1996 Jun;38(6):1096-103
|
|
|
|
